author-photo

Krishna V. Komanduri

University of Miami
University of Texas MD Anderson Cancer Center

245

Papers

8296

Citations

Citation Trend

Filter By

Papers (245) Sort By

Journal Conference Others

Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection

2021 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (1)
nLower incidence of Cytomegalovirus reactivation following post-transplant cyclophosphamide HLA mismatched unrelated donor transplantation

2021
Show All
- Source
- Cite
- Save
Citations (0)
Development of a Predictive Model for Cytokine Release Syndrome to Inform Risk Stratification and CRS Management Following Immunotherapy

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Post-Transplant cyclophosphamide is associated with increase in Non-CMV Herpesvirus infections in Acute leukemia and MDS patients.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Presentation and Outcomes of COVID-19 Following Hematopoietic Cell Transplantation

2021
Show All
- Source
- Cite
- Save
Citations (0)
Lack of correlation between the SARS-CoV-2 cycle threshold (Ct ) value and clinical outcomes in patients with COVID-19.

2021 Journal of Medical Virology
Show All
- Source
- Cite
- Save
Citations (0)
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.

2021 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Post-Transplant Cyclophosphamide Is Associated with Improved Clinical Outcomes in HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Outcomes in Acute Myeloid Leukemia (AML) Patients (Pts) Carrying Isocitrate Dehydrogenase (IDH1-2) Mutations Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

2021
Show All
- Source
- Cite
- Save
Citations (0)
Impact of Pre-Transplant Molecular Measurable Residual Disease (MMRD) and European Leukemianet (ELN) Genetic Classification in Clinical Outcomes for Acute Myeloid Leukemia (AML) Patients (Pts) Undergoing Allogeneic Stem Cell Transplantation (alloHCT)

2021
Show All
- Source
- Cite
- Save
Citations (0)